NCT00046670

Brief Summary

To examine the relationship between obstructive sleep apnea and lipid metabolism.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Sep 2002

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2002

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

September 30, 2002

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 1, 2002

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2007

Completed
Last Updated

March 5, 2014

Status Verified

March 1, 2014

Enrollment Period

4.6 years

First QC Date

September 30, 2002

Last Update Submit

March 4, 2014

Conditions

Sleep Apnea SyndromesLung Diseases

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
No eligibility criteria

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Related Publications (3)

  • Lin L, Finn L, Zhang J, Young T, Mignot E. Angiotensin-converting enzyme, sleep-disordered breathing, and hypertension. Am J Respir Crit Care Med. 2004 Dec 15;170(12):1349-53. doi: 10.1164/rccm.200405-616OC. Epub 2004 Sep 24.

    PMID: 15447944BACKGROUND

  • Gottlieb DJ, DeStefano AL, Foley DJ, Mignot E, Redline S, Givelber RJ, Young T. APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study. Neurology. 2004 Aug 24;63(4):664-8. doi: 10.1212/01.wnl.0000134671.99649.32.

    PMID: 15326239BACKGROUND

  • Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004 Dec;1(3):e62. doi: 10.1371/journal.pmed.0010062. Epub 2004 Dec 7.

    PMID: 15602591BACKGROUND

MeSH Terms

Conditions

Sleep Apnea SyndromesLung Diseases

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Emmanuel Mignot

    Stanford University

Study Design

Study Type
observational
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 30, 2002

First Posted

October 1, 2002

Study Start

September 1, 2002

Primary Completion

April 1, 2007

Study Completion

April 1, 2007

Last Updated

March 5, 2014

Record last verified: 2014-03